Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
Arduino UNO,Binary Image,Bluetooth Module,DC Power,Gesture Recognition,Hand Gesture Recognition,Hand Gestures,Hardware Implementation,Human-computer Interaction ...